2015 · 2015 International Symposium - Orlando · biomedical · Scientific

Theme 13: In vivo Experimental Models

When you think of Orlando you think vacations, theme parks and sunshine. However, for one weekend in December, ALS/MND researchers from around the globe gathered in America’s sunshine state for the 26th International Symposium on ALS/MND. This was the first Symposium I have attended during my PhD and I was excited to finally present all the research that the…… Continue reading Theme 13: In vivo Experimental Models

2015 · 2015 International Symposium - Orlando · Clinical · Healthcare · Insights

Session 2B: Clinical management

The first of the clinical sessions covered a variety of topics related to the clinical care and symptom management of patients with ALS/MND. This session opened with Professor Orla Hardiman from Ireland speaking about the importance of specialist multidisciplinary clinics in the care of ALS/MND patients. There is evidence that patients who attend such clinics…… Continue reading Session 2B: Clinical management

2015 · 2015 International Symposium - Orlando · Clinical · Insights

ALS Heterogeneity and progression

Here’s my blog from the fascinating session 4B at the Orlando Symposium. Ammar Al-Chalabi takes the stage to a disco effect of flashing lights that might be more appropriate for the next speaker’s lurid pink suit, but he promises controversy regardless. His starting point is a definition of ALS that is about as uncontroversial as…… Continue reading ALS Heterogeneity and progression

2015 · 2015 International Symposium - Orlando · biomedical · Insights · Scientific

Session 4A: Disease Models

Firstly, Dr Cathleen Lutz (The Jackson Laboratory, USA) discussed the range of current mouse models of MND and the potential for generating new models.  Lutz explored the many reasons why MND is a hard disease to model, and how the SOD1-G93A model has become the ‘workhorse’ for MND mouse modelling.  However, as subgroups and new…… Continue reading Session 4A: Disease Models